Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Interest & Investment Income: 2020-2024

Historic Interest & Investment Income for Krystal Biotech (KRYS) over the last 5 years, with Dec 2024 value amounting to $29.7 million.

  • Krystal Biotech's Interest & Investment Income fell 9.65% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year decrease of 3.82%. This contributed to the annual value of $29.7 million for FY2024, which is 31.10% up from last year.
  • As of FY2024, Krystal Biotech's Interest & Investment Income stood at $29.7 million, which was up 31.10% from $22.6 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Interest & Investment Income registered a high of $29.7 million during FY2024, and its lowest value of $197,000 during FY2021.
  • For the 3-year period, Krystal Biotech's Interest & Investment Income averaged around $19.2 million, with its median value being $22.6 million (2023).
  • Per our database at Business Quant, Krystal Biotech's Interest & Investment Income slumped by 76.32% in 2021 and then soared by 2,550.25% in 2022.
  • Yearly analysis of 5 years shows Krystal Biotech's Interest & Investment Income stood at $832,000 in 2020, then plummeted by 76.32% to $197,000 in 2021, then skyrocketed by 2,550.25% to $5.2 million in 2022, then spiked by 333.33% to $22.6 million in 2023, then surged by 31.10% to $29.7 million in 2024.